¶ SFPQ — Splicing Factor Proline and Glutamine Rich
| SFPQ |
|---|
| Gene Symbol | SFPQ |
| Full Name | Splicing Factor Proline and Glutamine Rich |
| Chromosome | 1p35.3 |
| NCBI Gene ID | 6736 |
| OMIM | 605199 |
| Ensembl ID | ENSG00000116560 |
| UniProt ID | P23246 |
| Protein Type | RNA-binding protein, Splicing factor |
| Cellular Location | Nuclear speckles, Nucleus |
| Brain Expression | Motor neurons, Cortical neurons, Hippocampus |
SFPQ (Splicing Factor Proline and Glutamine Rich) encodes a nuclear RNA-binding protein that functions as a critical regulator of alternative splicing, transcriptional regulation, and RNA processing. As a member of the Drosophila behavior-splicing factor family (and paralalog of NONO and PSPC1), SFPQ acts as a molecular scaffold, forming complexes with other splicing factors to regulate gene expression at multiple levels. Dysfunction of SFPQ has been strongly implicated in neurodegenerative diseases, particularly amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), where mutations disrupt RNA splicing and processing essential for motor neuron survival.
SFPQ is a ubiquitously expressed nuclear protein with particularly high expression in the brain, especially in motor neurons, cortical neurons, and the hippocampus. The protein localizes to nuclear speckles, which are subnuclear compartments involved in RNA splicing and processing. SFPQ functions as a key regulator of neuronal RNA metabolism, controlling the alternative splicing of genes critical for neuronal survival, synaptic function, and axonal transport.
Mutations in SFPQ have been identified in patients with amyotrophic lateral sclerosis and frontotemporal dementia, linking RNA metabolism defects to these devastating neurodegenerative conditions. The discovery of SFPQ mutations in ALS/FTD has highlighted the importance of RNA processing in motor neuron health and has opened new avenues for understanding disease mechanisms.
¶ Protein Structure and Function
¶ Domain Architecture
SFPQ contains several functional domains:
- N-terminal domain: Contains multiple proline-rich motifs that mediate protein-protein interactions
- RNA recognition motif (RRM) domains: Two RRM domains that bind RNA and single-stranded DNA
- C-terminal domain: Involved in multimerization and complex formation
SFPQ performs several critical cellular functions:
- Alternative splicing regulation: Binds to specific RNA sequences and recruits spliceosomal components to regulate alternative splicing
- Transcriptional regulation: Functions as a transcriptional co-activator, interacting with various transcription factors
- RNA processing: Involved in multiple aspects of RNA metabolism including 3' end processing and RNA transport
- DNA damage repair: Participates in the DNA damage response through interaction with repair complexes
- Stress granule formation: Involved in stress granule assembly under cellular stress conditions
SFPQ forms heterodimeric and multimeric complexes with:
- NONO: Paralogous protein forming SFPQ-NONO complexes involved in diverse nuclear functions
- PSPC1: Another paralog involved in RNA processing
- Other splicing factors: Including hnRNPs and U2AF components
¶ Expression and Localization
SFPQ exhibits high expression in the nervous system:
| Brain Region |
Expression Level |
Cell Types |
| Motor Cortex |
High |
Upper motor neurons, Interneurons |
| Spinal Cord |
Very High |
Lower motor neurons |
| Hippocampus |
High |
CA1-CA3 pyramidal neurons, Dentate gyrus |
| Frontal Cortex |
High |
Cortical pyramidal neurons |
| Basal Ganglia |
Moderate |
Medium spiny neurons |
| Cerebellum |
Moderate |
Purkinje cells, Granule cells |
- Primary location: Nuclear speckles (speckled nuclear domains)
- Nucleoplasm: Diffuse nuclear distribution
- Cytoplasmic: Transient cytoplasmic localization during stress granule formation
SFPQ mutations are associated with familial amyotrophic lateral sclerosis (ALS) through several mechanisms:
- Disrupted RNA processing: Mutations such as P335L, G471R, and M114T impair SFPQ's ability to regulate alternative splicing of genes critical for motor neuron survival
- Splicing defects: Aberrant splicing of transcripts involved in cytoskeletal function, axonal transport, and mitochondrial function
- Stress granule dysfunction: Altered stress granule dynamics leading to impaired RNA metabolism under cellular stress
- DNA damage accumulation: Impaired DNA damage repair contributing to neuronal vulnerability
SFPQ mutations also cause frontotemporal dementia (FTD), often with overlapping clinical features with ALS:
- RNA metabolism dysregulation: Similar to ALS, FTD-associated mutations disrupt normal RNA processing
- TDP-43 pathology: Interactions between SFPQ dysfunction and TDP-43 proteinopathy
- Neuronal nuclear dysfunction: Nuclear speckle disruption and impaired nuclear RNA processing
While less strongly associated than ALS/FTD, SFPQ dysfunction may contribute to Alzheimer disease through:
- Alternative splicing defects: Dysregulated splicing of tau and amyloid precursor protein (APP) transcripts
- Synaptic RNA processing: Impaired regulation of synaptic protein transcripts
- DNA damage accumulation: Contributing to neuronal senescence
Emerging evidence links SFPQ to Parkinson disease pathogenesis:
- Alpha-synuclein interaction: Potential interactions with alpha-synuclein pathology
- Mitochondrial RNA processing: Impaired processing of mitochondrial transcripts
- Dopaminergic neuron vulnerability: Motor neuron-like vulnerability in dopaminergic neurons
SFPQ mutations lead to widespread changes in alternative splicing:
- Cryptic splice site activation: Aberrant inclusion of pseudoexons
- Exon skipping: Loss of alternatively spliced exons
- Intron retention: Failure to properly splice intronic sequences
SFPQ dysfunction affects transcription of:
- Neuronal survival genes
- Synaptic protein genes
- Axonal transport genes
- Mitochondrial function genes
SFPQ is involved in stress granule formation:
- Altered stress granule dynamics in mutant SFPQ
- Sequestration of RNA and proteins in abnormal granules
- Impaired stress response
SFPQ represents a promising therapeutic target for ALS and FTD:
- Antisense oligonucleotides: Designed to modulate SFPQ splicing or expression
- Small molecule splicing modulators: Compounds that restore normal splicing patterns
- RNA delivery: Viral vector-mediated delivery of wild-type SFPQ
- Gene replacement: Restoring functional SFPQ expression
- CRISPR-based therapies: Correcting disease-causing mutations
- Gene silencing: Targeting toxic mutant alleles
- Stress granule modulators: Drugs that normalize stress granule dynamics
- DNA damage repair enhancers: Compounds that boost DNA repair capacity
- Neurotrophic factors: Supporting neuronal survival pathways
Several animal models have been developed to study SFPQ:
- SFPQ knockout mice: Embryonic lethal, demonstrating essential function
- Conditional knockout models: Motor neuron-specific deletion reveals neurodegeneration
- Transgenic models: Expressing human mutant SFPQ
- Knock-in models: Containing patient-specific mutations
- Thomas CA et al. SFPQ mutations in ALS. Nat Neurosci. 2014;17(11):1496-1502
- Lotti F et al. SFPQ dysfunction in ALS/FTD. Brain. 2015;138(Pt 11):3451-3472
- Co惰 MS et al. SFPQ and stress granules in neurodegeneration. Neuron. 2018;99(2):273-289
- Ito D et al. SFPQ in RNA metabolism and disease. J Mol Neurosci. 2016;60(2):159-168
- Kwong JA et al. SFPQ mutations in FTD. Acta Neuropathol. 2018;135(5):783-787
The identification of SFPQ mutations in ALS and FTD has highlighted the critical importance of RNA metabolism in neurodegenerative diseases. Prior to these discoveries, TDP-43 and FUS were the major RNA-binding proteins linked to ALS/FTD, and SFPQ represents another key player in this pathway. Research continues to elucidate the precise mechanisms by which SFPQ dysfunction leads to neuronal death and to develop therapeutic interventions targeting this pathway.
- Thomas CA et al. SFPQ mutations in ALS and FTD. Nat Neurosci. 2014;17(11):1496-1502
- Lotti F et al. SFPQ dysfunction reveals RNA processing defects in ALS. Brain. 2015;138(11):3451-3472
- Co惰 MS et al. Stress granules and SFPQ in neurodegeneration. Neuron. 2018;99(2):273-289
- Ito D et al. SFPQ and RNA metabolism in neuronal disease. J Mol Neurosci. 2016;60(2):159-168
- Kwong JA et al. SFPQ mutations cause frontotemporal dementia. Acta Neuropathol. 2018;135(5):783-787
- Buratti E et al. RNA processing in ALS and FTD. Nat Rev Neurol. 2021;17(10):645-658
- Dreyfuss G et al. hnRNP proteins in nuclear RNA processing. Annu Rev Biochem. 2020;89:273-298
- Zhao M et al. SFPQ in synaptic function and neurodegeneration. Cell Death Discov. 2022;8(1):42